Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Outcomes of patients with oesophageal cancer treated with preoperative chemoradiotherapy, followed by tumor resection: influence of nutritional factors

M. Zemanova, F. Novak, P. Vitek, A. Pazdro, M. Smejkal, G. Pazdrova, L. Petruzelka

. 2012 ; 17 (2) : 310-316.

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12034441

Grantová podpora
NT12331 MZ0 CEP - Centrální evidence projektů

PURPOSE: To assess the impact of clinical and nutritional factors on overall survival (OS) and time to disease progression of oesophageal cancer patients treated with neoadjuvant chemoradiotherapy (CRT) and surgery. METHODS: We retrospectively studied and analysed several clinical and nutritional factors, such as performance status, weight changes before and during CRT, dysphagia, nutritional support, and serum albumin to see whether they exerted any impact on OS and time to disease progression. RESULTS: In 107 patients the average weight loss was 9.7% from the onset of signs of disease to the beginning of therapy and 3% during CRT. In univariate analysis, significant unfavorable impact on survival was proved for low performance status, severe dysphagia, need for nasogastric tube insertion, above-average weight loss before treatment, weight loss >5% during CRT, and serum albumin ≤ 35 g/l before or after CRT. Patients supported by oral nutritional supplements (ONS) had higher probability to attain full dosage of CRT and radical resection than did those obtaining dietary advice alone. In multivariate analysis, serum albumin level, nasogastric (NG) tube insertion and pretreatment body weight loss were independent prognostic factors for OS, while serum albumin level after CRT and NG tube insertion were prognosticators for time to progression. CONCLUSION: Serum albumin level can serve as a useful prognostic factor for the outcome of patients with oesophageal cancer treated with neoadjuvant CRT and surgery. Appropriate nutritional support of these patients increased the probability of attaining full dosage of CRT and radical disease resection.

000      
00000naa a2200000 a 4500
001      
bmc12034441
003      
CZ-PrNML
005      
20181213105516.0
007      
ta
008      
121023s2012 gr f 000 0|eng||
009      
AR
035    __
$a (PubMed)22740211
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Zemanová, Milada $7 xx0060597 $u Charles University and General University Hospital in Prague, Prague, Czech Republic. milada.zemanova@vfn.cz
245    10
$a Outcomes of patients with oesophageal cancer treated with preoperative chemoradiotherapy, followed by tumor resection: influence of nutritional factors / $c M. Zemanova, F. Novak, P. Vitek, A. Pazdro, M. Smejkal, G. Pazdrova, L. Petruzelka
520    9_
$a PURPOSE: To assess the impact of clinical and nutritional factors on overall survival (OS) and time to disease progression of oesophageal cancer patients treated with neoadjuvant chemoradiotherapy (CRT) and surgery. METHODS: We retrospectively studied and analysed several clinical and nutritional factors, such as performance status, weight changes before and during CRT, dysphagia, nutritional support, and serum albumin to see whether they exerted any impact on OS and time to disease progression. RESULTS: In 107 patients the average weight loss was 9.7% from the onset of signs of disease to the beginning of therapy and 3% during CRT. In univariate analysis, significant unfavorable impact on survival was proved for low performance status, severe dysphagia, need for nasogastric tube insertion, above-average weight loss before treatment, weight loss >5% during CRT, and serum albumin ≤ 35 g/l before or after CRT. Patients supported by oral nutritional supplements (ONS) had higher probability to attain full dosage of CRT and radical resection than did those obtaining dietary advice alone. In multivariate analysis, serum albumin level, nasogastric (NG) tube insertion and pretreatment body weight loss were independent prognostic factors for OS, while serum albumin level after CRT and NG tube insertion were prognosticators for time to progression. CONCLUSION: Serum albumin level can serve as a useful prognostic factor for the outcome of patients with oesophageal cancer treated with neoadjuvant CRT and surgery. Appropriate nutritional support of these patients increased the probability of attaining full dosage of CRT and radical disease resection.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a protokoly protinádorové kombinované chemoterapie $x terapeutické užití $7 D000971
650    _2
$a kombinovaná terapie $7 D003131
650    _2
$a poruchy polykání $7 D003680
650    _2
$a progrese nemoci $7 D018450
650    _2
$a nádory jícnu $x mortalita $x terapie $7 D004938
650    _2
$a ezofagektomie $7 D016629
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neoadjuvantní terapie $7 D020360
650    _2
$a nutriční stav $7 D009752
650    _2
$a předoperační péče $7 D011300
650    _2
$a prognóza $7 D011379
650    _2
$a celková dávka radioterapie $7 D011879
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a časové faktory $7 D013997
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Novák, František Jindřich, $d 1941-1993 $7 xx0023663 $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Vítek, Pavel, $d 1960- $7 mzk2006322806 $u Kooperativní skupina pro neuroendokrinní nádory o. s., Praha. p-vitek@email.cz
700    1_
$a Pazdro, Alexandr $7 xx0093307 $u III. chirurgická klinika FN Praha-Motol. sasa.pazdro@lfmotol.cuni.cz
700    1_
$a Smejkal, Milan $7 xx0137280 $u Chirurgische Klinik des Universitätskrankenhauses Motol. smejkal2@seznam.cz
700    1_
$a Pazdrová, Gabriela $7 xx0093308 $u Department of Oncology, I Medical Faculty of Charles University, Prague
700    1_
$a Petruželka, Luboš, $d 1952- $7 jn19990209650 $u Department of Oncology, I Medical Faculty of Charles University, Prague
773    0_
$w MED00005361 $t Journal of B.U.ON. official journal of the Balkan Union of Oncology $x 1107-0625 $g Roč. 17, č. 2 (2012), s. 310-316
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22740211 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20121023 $b ABA008
991    __
$a 20181213105641 $b ABA008
999    __
$a ok $b bmc $g 956451 $s 791938
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 17 $c 2 $d 310-316 $i 1107-0625 $m Journal of Balkan Union of Oncology $n J BUON $x MED00005361
GRA    __
$a NT12331 $p MZ0
LZP    __
$b NLK122 $a Pubmed-20121023

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace